Jeremias Motte Selected Research

Neuritis (Polyneuritis)

3/2019	Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells.
4/2018	Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.
1/2017	Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.
1/2017	Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremias Motte Research Topics

Disease

7	Experimental Autoimmune Neuritis 01/2021 - 01/2017
5	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2022 - 01/2019
4	Neuritis (Polyneuritis) 03/2019 - 01/2017
3	Polyneuropathies (Polyneuropathy) 05/2022 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 04/2018
2	Multiple Sclerosis 12/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 03/2020 - 04/2018
2	Demyelinating Diseases (Demyelinating Disease) 03/2019 - 04/2018
2	CADASIL 01/2018 - 01/2014
1	Pain (Aches) 01/2022
1	Paresthesia (Dysesthesia) 12/2021
1	Multiple Myeloma 01/2021
1	Postural Orthostatic Tachycardia Syndrome 01/2021
1	Hyperalgesia 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Paralysis (Palsy) 01/2020
1	Seizures (Absence Seizure) 12/2019
1	Hyperprolinemia type 2 12/2019
1	Disease Progression 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Lymphopenia (Lymphocytopenia) 08/2018
1	Horner Syndrome (Horner's Syndrome) 05/2017
1	Autoimmune Pancreatitis 05/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2021 - 01/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021 - 03/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Capsaicin (Zostrix)FDA Link 05/2020 - 04/2018
2	P2 peptideIBA 03/2019 - 01/2017
2	Dimethyl FumarateIBA 01/2019 - 08/2018
2	Retinaldehyde (Retinal)IBA 01/2018 - 01/2014
1	Pain-FreeIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	Biotin (Vitamin H)FDA Link 12/2020
1	Transient Receptor Potential ChannelsIBA 05/2020
1	Immunoglobulin G (IgG)IBA 03/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Proline (L-Proline)FDA Link 12/2019
1	Triamcinolone (Aristocort)FDA Link 03/2019
1	SteroidsIBA 03/2019
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2019
1	Therapeutic UsesIBA 03/2019
1	hydroxide ionIBA 01/2019
1	Hydroxocobalamin FDA Link 01/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Rapeseed OilIBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2014

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2017
1	Drug Therapy (Chemotherapy) 05/2022
1	Artificial Respiration (Mechanical Ventilation) 12/2021
1	Spinal Injections 03/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Lasers (Laser) 01/2014